Cargando…

A 27-Year-Old Primigravida with a Right Renal Cell Carcinoma Removed at 30 Weeks of Gestation by Robot-Assisted Retroperitoneoscopic Partial Nephrectomy

Patient: Female, 27-year-old Final Diagnosis: Renal cell carcinoma Symptoms: Asymptomatic Medication: — Clinical Procedure: — Specialty: Oncology • Urology OBJECTIVE: Rare disease BACKGROUND: Large renal tumors during pregnancy are rare findings (0.07–0.1%). Current guidelines recommend surgical rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Völler, Moritz, Mahmud, Walid, Vallo, Stefan, Grabbert, Markus, John, Patricia, Khoder, Wael Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063764/
https://www.ncbi.nlm.nih.gov/pubmed/33866322
http://dx.doi.org/10.12659/AJCR.927164
Descripción
Sumario:Patient: Female, 27-year-old Final Diagnosis: Renal cell carcinoma Symptoms: Asymptomatic Medication: — Clinical Procedure: — Specialty: Oncology • Urology OBJECTIVE: Rare disease BACKGROUND: Large renal tumors during pregnancy are rare findings (0.07–0.1%). Current guidelines recommend surgical removal. This surgery should be carefully planned in an interdisciplinary team and involves special risks for mother and fetus. This report describes a case of a 27-year-old primigravida woman with a right renal cell carcinoma involving the lower pole of the kidney, which was removed at 30 weeks of gestation by robot-assisted retroperitoneoscopic partial nephrectomy (RARPN). CASE REPORT: The patient was referred by the treating obstetrician with a newly diagnosed right lower pole renal mass of 6×4 cm in greatest diameter extending deeply into the parenchyma. No metastasis or enlarged lymph nodes were described in subsequent magnetic resonance tomography. Clinical and laboratory examinations documented a healthy mother and fetus. A right-sided RARPN was advised and planned by an interdisciplinary team of treating physicians (gynecologists, oncologists, and urologists). The surgery was conducted under general anesthesia with an obstetrician on stand-by. Surgery was performed without any complications (operation time 95 min, renal-ischemia time 15 min, and negligible blood loss) and histopathology confirmed the diagnosis of a chromophobe renal cell carcinoma. Further follow-up consultations showed regular wound healing and normal progression of pregnancy, and the patient gave birth to a healthy child at term. Follow-up examinations of the patient were uneventful. CONCLUSIONS: This case shows that RARPN can be a safe and effective surgical procedure for partial nephrectomy during pregnancy, where surgery is performed in a specialist center and by an interdisciplinary experienced surgical team. It seems to offer advantages and better risk profile over the laparoscopic approach.